(Q51597632)

English

The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart disease.

scientific article published in January 1994

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7915237

The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart disease. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7915237

1 reference

based on heuristic

inferred from title

author name string

R A Wright

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7915237

A M Perrie

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7915237

F Stenhouse

3

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7915237

K G Alberti

4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7915237

R A Riemersma

5

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7915237

I R MacGregor

6

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7915237

N A Boon

7

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7915237

publication date

1 January 1994

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7915237

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7915237

46

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7915237

3

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7915237

279-282

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7915237

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/7915237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/7915237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7915237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasminogen activator inhibitor (PAI-1) in plasma and platelets

1 reference

https://pubmed.ncbi.nlm.nih.gov/7915237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of nadolol on hemodynamic and hemostatic responses to potential mental and physical triggers of myocardial infarction in subjects with mild systemic hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7915237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292

1 reference

https://pubmed.ncbi.nlm.nih.gov/7915237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction study between nifedipine and recombinant tissue-type plasminogen activator in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/7915237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/7915237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent studies on the effects of beta blockers on blood lipid levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/7915237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Critical Variables in the Radioimmunoassay of Serum Insulin Using the Double Antibody Technic

1 reference

https://pubmed.ncbi.nlm.nih.gov/7915237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of metoprolol treatment on sympatho-adrenal activation of fibrinolysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7915237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of metoprolol CR/ZOK on plasminogen activator inhibitor (PAI-1) in man: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7915237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/7915237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris

1 reference

https://pubmed.ncbi.nlm.nih.gov/7915237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response

1 reference

https://pubmed.ncbi.nlm.nih.gov/7915237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibrinogen and plasminogen activator inhibitor-1 levels in hypertension and coronary heart disease. Potential effects of beta-blockade.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7915237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of long-term beta-blockade with alprenolol on platelet function and fibrinolytic activity in patients with coronary heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/7915237

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00192563

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7915237

release_ncm5vs5nyjctrihqqwqoanlhs4

1 reference

https://api.fatcat.wiki/v0/release/ncm5vs5nyjctrihqqwqoanlhs4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/7915237

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51597632&oldid=2210987983"